Back to mobile site

Leerink Affirms Merck (MRK) at 'Market Perform'; Additional KEYTRUDA Data Still Needed

October 26, 2015 2:29 PM EDT Send to a Friend
Leerink affirms Merck (NYSE: MRK) at Market Perform with a price target of $67 after the company announced topline results ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login